HedgeChatter

  • Home /
  • Tag Archives

MDXG

MiMedx Group’s CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Pete Petit Thank you, Thornton and welcome to our year end 2013 conference call. I have with me this morning Bill Taylor, our President and Chief Operating Officer; and Mike Senken, our Chief Financial … moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring […]

February 26, 2014 Bystocknews , Comments Off on MiMedx Group’s CEO Discusses Q4 2013 Results – Earnings Call Transcript read more

MiMedx reports Q4 EPS (1c), consensus (1c)

moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on MiMedx reports Q4 EPS (1c), consensus (1c) read more

MiMedx Announces Record 2013 Results

[PR Newswire] – MARIETTA, Ga., Feb. 26, 2014 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG) , an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed … moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on MiMedx Announces Record 2013 Results read more

1:34 am MiMedx Group reports second EpiFix randomized comparative study was published in International Wound Journal showing 92% healing rate over 12 weeks

moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on 1:34 am MiMedx Group reports second EpiFix randomized comparative study was published in International Wound Journal showing 92% healing rate over 12 weeks read more

Second MiMedx EpiFix® Randomized Comparative Study Published In International Wound Journal Shows 92.5% Healing Rate Over 12 Weeks

[PR Newswire] – MARIETTA, Ga., Feb. 25, 2014 /PRNewswire/ — MiMedx Group, Inc. (MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced tod moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on Second MiMedx EpiFix® Randomized Comparative Study Published In International Wound Journal Shows 92.5% Healing Rate Over 12 Weeks read more

MiMedx EpiFix allograft awarded coverage by HCSC

moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on MiMedx EpiFix allograft awarded coverage by HCSC read more

MiMedx EpiFix® Allograft Awarded Coverage by HCSC

[PR Newswire] – MARIETTA, Ga., Feb. 12, 2014 /PRNewswire/ — MiMedx Group, Inc. (MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced tod moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

February 12, 2014 Bystocknews , Comments Off on MiMedx EpiFix® Allograft Awarded Coverage by HCSC read more